SGLT2 inhibitor and DPP-4 inhibitor combination

This page covers all SGLT2 inhibitor and DPP-4 inhibitor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SGLT2 (sodium-glucose cotransporter 2) and DPP-4 (dipeptidyl peptidase-4).

Targets

SGLT2 (sodium-glucose cotransporter 2) and DPP-4 (dipeptidyl peptidase-4)

Marketed (1)

• SGLT2 inhibitor and DPP-4 inhibitor · LMC Diabetes & Endocrinology Ltd. · Diabetes
  This combination drug lowers blood glucose by blocking kidney glucose reabsorption (SGLT2 inhibitor) and slowing incretin hormone breakdown (DPP-4 inhibitor).

Patent intelligence

• sglt2 inhibitor and dpp 4 inhibitor combination patent landscape — aggregated cliff calendar, attackable patents, originator estates